Wireless CRT Advantage Position WiSE CRT as a pioneering, leadless cardiac resynchronization therapy that addresses complications from traditional CRT leads, highlighting a differentiated value proposition for heart failure clinics and electrophysiology centers seeking safer, cost-effective therapies.

US Commercialization Target US hospitals and cardio-surgical centers for rapid deployment of WiSE products, leveraging recent launches like the WiSE Coupler to expand adoption and support scale in a high-value, reimbursement-driven market.

Strategic Partnerships Explore collaborations with distributors, implant centers, and hospital systems to accelerate sales cycles, supported by the company’s growing capital and ongoing media visibility around product extensions.

Data Security & Compliance Address potential data breach and network disruption concerns proactively by showcasing robust cybersecurity and incident response capabilities to reassure healthcare customers handling sensitive patient data.

Growth Financing Evidence Leverage recent large-scale funding and investor interest to build credibility with prospective customers and partners, using financing milestones to create financing and procurement discussions.